Giant ascending aortic aneurysm with impending rupture as presentation of cutis laxa 1B: a case report

Background Thoracic aortic aneurysms are rarely symptomatic but can result in acute aortic syndromes, associated with a high mortality rate. While most cases may be acquired, a genetic basis is evident in approximately 20-25% of the cases, especially among patients under 50 years of age, and those e...

ver descrição completa

Detalhes bibliográficos
Autores: Used Gavin, Alejandro, Larrañaga Moreira, José María, Lago Cascudo, Rafael, Mosquera Rodríguez, Victor X, Barriales Villa, Roberto
Formato: artículo
Fecha de publicación:2023
País:España
Recursos:Servizo Galego de Saúde (SERGAS)
Repositorio:RUNA. Repositorio da Consellería de Sanidade e Sergas
OAI Identifier:oai:runa.sergas.gal:20.500.11940/21575
Acesso em linha:https://portalcientifico.sergas.gal//documentos/65c7d9739c40e53c350f95d3
http://hdl.handle.net/20.500.11940/21575
Access Level:acceso abierto
Palavra-chave:AS A Coruña
CHUAC
AS Ferrol
CHUF
Descrição
Resumo:Background Thoracic aortic aneurysms are rarely symptomatic but can result in acute aortic syndromes, associated with a high mortality rate. While most cases may be acquired, a genetic basis is evident in approximately 20-25% of the cases, especially among patients under 50 years of age, and those exhibiting syndromic features or family history. Although autosomal dominant inheritance is predominant in familial aortopathies, exceptions exist, such as cutis laxa 1B (CL1B)-related aortic disease, caused by variants in EFEMP2 gene, that follows an autosomal recessive inheritance pattern Case summary We present the case of a 26-year-old male with a giant ascending aorta aneurysm and massive pericardial effusion, which was ultimately diagnosed of CL1B due to the p.Ser137Cys variant in the EFEMP2 gene in homozygosis. The patient underwent successful ascending aorta replacement (Bentall´s procedure). There were not complications or further events after 2 years of follow-up Discussion This case underscores the importance of genetic testing in young patients presenting with aortopathies, syndromic features, or atypical presentations, irrespective of family history.